Related Experiment Video
Updated: Mar 20, 2026

Single-Port Robotic-assisted Transaxillary Breast-conserving Surgery: A Prospective, Single-arm, Non-randomized Phase IIa Clinical Trial
Published on: August 19, 2025
Controversies in Breast Cancer Screening Strategies
Therese Bevers1, Kirsten Bibbins-Domingo1, Kevin C Oeffinger1
1Presented by Therese Bevers, MD, The University of Texas MD Anderson Cancer Center, Houston, Texas, and Chair of the NCCN Guidelines for Breast Cancer Screening and Diagnosis; Kirsten Bibbins-Domingo, PhD, MD, MAS, University of California, San Francisco, San Francisco, California, and Chair of the U.S. Preventive Services Task Force; and Kevin C. Oeffinger, MD, Memorial Sloan Kettering Cancer Center, New York, New York, and Chair of the American Cancer Society Breast Cancer Screening Guideline Panel; facilitated by Mary Lou Smith, JD, MBA, Research Advocacy Network, Naperville, Illinois.
Abstract:
A panel discussion on controversies in breast cancer screening held recently at the NCCN 21st Annual Conference included only a few controversies. Representatives of the U.S. Preventive Services Task Force, American Cancer Society, and NCCN disagreed primarily on 2 main areas: when to start screening (ages 40, 45, or 50 years) and frequency of screening (annual vs biennial). Panelists from these organizations presented the rationales for their respective recommendations.
More Related Videos
06:03Integrating Augmented Reality Tools in Breast Cancer Related Lymphedema Prognostication and Diagnosis
Published on: February 6, 2020
11:34Building Up a High-throughput Screening Platform to Assess the Heterogeneity of HER2 Gene Amplification in Breast Cancers
Published on: December 5, 2017